Abstract:Importance: Electronic health records (EHRs) provide a low-cost means of accessing detailed longitudinal clinical data for large populations. A lung cancer cohort assembled from EHR data would be a powerful platform for clinical outcome studies. Objective: To investigate whether a clinical cohort assembled from EHRs could be used in a lung cancer prognosis study. Design, setting, and participants: In this cohort study, patients with lung cancer were identified among 76 643 patients with at least 1 lung cancer diagnostic code deposited in an EHR in Mass General Brigham health care system from July 1988 to October 2018. Patients were identified via a semisupervised machine learning algorithm, for which clinical information was extracted from structured and unstructured data via natural language processing tools. Data completeness and accuracy were assessed by comparing with the Boston Lung Cancer Study and against criterion standard EHR review results. A prognostic model for non-small cell lung cancer (NSCLC) overall survival was further developed for clinical application. Data were analyzed from March 2019 through July 2020. Exposures: Clinical data deposited in EHRs for cohort construction and variables of interest for the prognostic model were collected. Main outcomes and measures: The primary outcomes were the performance of the lung cancer classification model and the quality of the extracted variables; the secondary outcome was the performance of the prognostic model. Results: Among 76 643 patients with at least 1 lung cancer diagnostic code, 42 069 patients were identified as having lung cancer, with a positive predictive value of 94.4%. The study cohort consisted of 35 375 patients (16 613 men [47.0%] and 18 756 women [53.0%]; 30 140 White individuals [85.2%], 1040 Black individuals [2.9%], and 857 Asian individuals [2.4%]) after excluding patients with lung cancer history and less than 14 days of follow-up after initial diagnosis. The median (interquartile range) age at diagnosis was 66.7 (58.4-74.1) years. The area under the receiver operating characteristic curves of the prognostic model for overall survival with NSCLC were 0.828 (95% CI, 0.815-0.842) for 1-year prediction, 0.825 (95% CI, 0.812-0.836) for 2-year prediction, 0.814 (95% CI, 0.800-0.826) for 3-year prediction, 0.814 (95% CI, 0.799-0.828) for 4-year prediction, and 0.812 (95% CI, 0.798-0.825) for 5-year prediction. Conclusions and relevance: These findings suggest the feasibility of assembling a large-scale EHR-based lung cancer cohort with detailed longitudinal clinical measurements and that EHR data may be applied in cancer progression with a set of generalizable approaches.

A survey of pattern classification-based methods for predicting survival time of lung cancer patients

Hand-Crafted and Deep Learning-Based Radiomics Models for Recurrence Prediction of Non-Small Cells Lung Cancers

Prediction of lung cancer patient survival via supervised machine learning classification techniques

Evaluation of Machine Learning Algorithms for the Prognosis of Breast Cancer from the Surveillance, Epidemiology, and End Results Database

Artificial Intelligence-based Prediction for Cancer Susceptibility,Recurrence and Survival br

Developing Prognostic Gene Panel of Survival Time in Lung Adenocarcinoma Patients Using Machine Learning

A gene expression signature predicts survival of patients with stage I non-small cell lung cancer.

Multimodal Learning for Non-small Cell Lung Cancer Prognosis

Understanding Prognostic Gene Expression Signatures in Lung Cancer

Comprehensive Evaluation of Machine Learning Models and Gene Expression Signatures for Prostate Cancer Prognosis Using Large Population Cohorts

Developing Prognostic Systems of Cancer Patients by Ensemble Clustering

Construction and validation of a novel prediction system for detection of overall survival in lung cancer patients

Performance of a Machine Learning Algorithm Using Electronic Health Record Data to Identify and Estimate Survival in a Longitudinal Cohort of Patients With Lung Cancer

Radiomics-based Prognosis Analysis for Non-Small Cell Lung Cancer

Survival Prediction in Non-Small Cell Lung Cancer Patients: Performance Evaluation of Machine Learning Ensemble Models (Preprint)

A deep learning‐ and CT image‐based prognostic model for the prediction of survival in non‐small cell lung cancer

Integrating Biological Knowledge with Gene Expression Profiles for Survival Prediction of Cancer

A Clustering Approach in Developing Prognostic Systems of Cancer Patients

Application and comparison of several machine learning methods in the prognosis of cervical cancer

Integrating Single-Cell and Bulk Expression Data to Identify and Analyze Cancer Prognosis-Related Genes

Machine learning applications in breast cancer survival and therapeutic outcome prediction based on multi-omic analysis